NextCell Pharma AB (NXTCL.ST)
SEK 2.42
(-13.57%)
SEK 2.42
(-13.57%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 10.66 Million | 10.11 Million | 5.58 Million | 3.91 Million | 3.56 Million | 1.81 Million |
| Cost of Revenue | 54.41 Million | 10.99 Million | 27.84 Million | 18.43 Million | 13.93 Million | 15.82 Million |
| Gross Profit | -43.74 Million | -884.83 Thousand | -22.26 Million | -14.52 Million | -10.37 Million | -14.01 Million |
| Operating Expenses | -576.01 Thousand | 40.11 Million | 12.76 Million | 10.38 Million | 7.32 Million | 7.44 Million |
| Selling, General and Administrative Expenses | -576.01 Thousand | 43.47 Million | 31.85 Million | 8.5 Million | 7.17 Million | 10.2 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 40.11 Million | 12.76 Million | 1.88 Million | 156.35 Thousand | -2.76 Million |
| Cost and Expenses | 53.83 Million | 51.11 Million | 40.61 Million | 28.82 Million | 21.26 Million | 23.26 Million |
| Operating Income | -43.17 Million | -41 Million | -35.02 Million | -24.82 Million | -17.7 Million | -21.45 Million |
| Interest Expense | 1357.00 | 2812.00 | 13.52 Thousand | 7573.00 | 8838.00 | 7787.00 |
| Income Tax Expense | - | 1.19 Million | -469.56 Thousand | 7573.00 | 8838.00 | 7787.00 |
| Earnings before Tax | -41.95 Million | -39.81 Million | -34.55 Million | -24.55 Million | -17.68 Million | -21.45 Million |
| Net Income | -41.95 Million | -39.81 Million | -34.08 Million | -24.56 Million | -17.68 Million | -21.45 Million |
| Earnings Per Share Basic | -1.03 | -1.16 | -1.01 | -0.81 | -0.89 | -1.45 |
| Earnings Per Share Diluted | -1.03 | -1.16 | -1.01 | -0.81 | -0.89 | -1.45 |
| Weighted Average Shares Outstanding | 40.81 Million | 34.37 Million | 34.37 Million | 30.41 Million | 19.86 Million | 12.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.81 Million | 34.37 Million | 34.37 Million | 30.41 Million | 19.86 Million | 12.37 Million |
| Gross Margin | -4.10 | -0.09 | -3.98 | -3.71 | -2.91 | -7.73 |
| EBIT Margin | -3.84 | -3.89 | -6.10 | -6.16 | -4.85 | -11.64 |
| Profit Margin | -3.93 | -3.94 | -6.10 | -6.28 | -4.96 | -11.84 |
| EBITDA | -40.98 Million | -39.36 Million | -34.09 Million | -24.21 Million | -17.28 Million | -17.64 Million |
| Earnings Before Tax Margin | -4.05 | -4.05 | -6.27 | -6.34 | -4.97 | -11.84 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 1.64 Million | 2.44 Million | 2.33 Million | 4.24 Million | 2.82 Million | 10.11 Million |
| Cost of Revenue | 15.27 Million | 11.47 Million | 2.75 Million | 2.66 Million | 2.71 Million | 10.99 Million |
| Gross Profit | -13.63 Million | -9.03 Million | -422.74 Thousand | 1.57 Million | 112.72 Thousand | -884.83 Thousand |
| Operating Expenses | - | 8.74 Million | 9.97 Million | 11.74 Million | 9.07 Million | 40.11 Million |
| Selling, General and Administrative Expenses | - | 8.67 Million | 9.93 Million | 12.08 Million | 10.13 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -3.00 | - | - | - | - |
| Cost and Expenses | 15.27 Million | 11.47 Million | 12.73 Million | 14.4 Million | 11.79 Million | 51.11 Million |
| Operating Income | -13.63 Million | -9.03 Million | -10.39 Million | -10.16 Million | -8.96 Million | -41 Million |
| Interest Expense | - | 176.00 | 879.00 | - | 42.00 | 2812.00 |
| Income Tax Expense | 383.44 Thousand | 2.00 | 305.47 Thousand | 367.36 Thousand | 395.95 Thousand | 1.19 Million |
| Earnings before Tax | -13.24 Million | -8.82 Million | -10.09 Million | -9.79 Million | -8.56 Million | -39.81 Million |
| Net Income | -13.24 Million | -8.82 Million | -10.09 Million | -9.79 Million | -8.56 Million | -39.81 Million |
| Earnings Per Share Basic | -0.22 | -0.26 | -0.29 | -0.28 | -0.25 | - |
| Earnings Per Share Diluted | -0.22 | -0.26 | -0.29 | -0.28 | -0.25 | - |
| Weighted Average Shares Outstanding | 59.97 Million | 34.37 Million | 34.37 Million | 34.37 Million | 34.37 Million | 34.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.97 Million | 34.37 Million | 34.37 Million | 34.37 Million | 34.37 Million | 34.37 Million |
| Gross Margin | -8.30 | -3.70 | -0.18 | 0.37 | 0.04 | -0.09 |
| EBIT Margin | -7.67 | -3.66 | -4.28 | -2.28 | -2.99 | - |
| Profit Margin | -8.07 | -3.61 | -4.32 | -2.31 | -3.03 | -3.94 |
| EBITDA | -12.6 Million | -8.92 Million | -9.97 Million | -9.68 Million | -8.45 Million | - |
| Earnings Before Tax Margin | -8.30 | -3.70 | -4.45 | -2.39 | -3.17 | -4.05 |
ZYXI
NNSB
4563
4078
CNXN
FRWDF